For adults with Type 2 Diabetes this clinical study may be of interest to you.
We are looking for adults 18 years of age or older who are diagnosed with Type 2 Diabetes. The clinical study will evaluate the effectiveness of a once-weekly investigational combination product, IcoSema, in participants with type 2 diabetes inadequately controlled with daily basal insulin.
For more information, or to see if you qualify to participate in this study, call Metabolic Research Institute Inc. (561) 802-3060, ext. 8036 or visit: https://www.metabolic-institute.com/weekly-injection/
Fatty Liver Disease (NASH) Clinical Research Study – Enrolling Now in West Palm Beach FL
Learn more about the EMMPACT study for nonalcoholic fatty liver disease. This study is researching if an investigational study drug is effective in helping people with confirmed or suspected NASH and fibrosis.